The government has announced plans to inject an extra £3.5 billion a year into primary and community healthcare by 2023/24, calling the investment a “historic commitment” to increasing the proportion of NHS funding spent on primary and community services.
23rd November 2018
Penn Medicine has launched its first European presence in London, in a move that aims to expand access to innovations pioneered by its physicians in the US to patients in the UK and Europe.
23rd November 2018
PharmaTimes are pleased to announce we will be partnering with MAGI to bring the Clinical Researcher of the Year competition to new audiences in the Americas.
22nd November 2018
MSD’s Keytruda should be funded on the NHS via the Cancer Drugs Fund for patients with the certain forms of lung cancer, according to draft guidance from the National Institute for Health and Care Excellence.
22nd November 2018
Over a quarter of UK pharmacists still don’t believe their skills are being properly utilised by the public, and just 5% think the UK public are aware of the level of expertise that they have, new research shows.
22nd November 2018
One third of patients with chronic obstructive pulmonary disease (COPD) feel they would receive better care if they had cancer, diabetes or heart disease, according to a new Chiesi-sponsored patient survey.
22nd November 2018
The UK’s cell and gene therapy industry has seen a 60% increase in manufacturing space in the last year, new research published by the Cell and Gene Therapy (CGT) Catapult has revealed.
22nd November 2018
GlaxoSmithKline has retained its top position among a global list of pharmaceutical companies striving to make their medicines, vaccines and diagnostics more accessible for people in low- and middle-income countries.
21st November 2018
US regulators have approved Swedish Orphan Biovitrum (Sobi) and Novimmune’s Gamifant as the first treatment for the rare disorder primary haemophagocytic lymphohistiocytosis.
21st November 2018
The European Commission has given its blessing for the proposed £46-billion acquisition of Shire by Takeda, paving the way for the deal's completion.
21st November 2018
More than half of patients who finished psychological therapy recovered in 2017-18, marking the first time the recovery rate has passed 50%.
21st November 2018
Eli Lilly has confirmed that Emgality, a once-monthly monoclonal antibody injection, has been approved by the European Commission for preventive treatment of migraine in adults who have at least four migraine days per month.
21st November 2018
Refractory coeliac disease, a deadly form of the autoimmune condition coeliac disease, has received its first dedicated support from NHS England, with the setting up of a Rare Disease Collaborative Network (RDCN) to accelerate research and treatment into this life threatening condition.
20th November 2018
Mirati Therapeutics has joined Cancer Research UK’s Stratified Medicine Programme, bringing new investigational treatment options to eligible patients with advanced lung cancer.
20th November 2018
GlaxoSmithKline is seeking to expand the use of its biologic Nucala in the US to include children aged six to 11 years with severe eosinophilic asthma.
20th November 2018
